Navigation Links
Nile Therapeutics Announces Filing of Annual and Quarterly Reports to Become Current on SEC Filings
Date:6/21/2013

SAN MATEO, Calif., June 21, 2013 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that is developing novel therapeutics for heart failure patients, today announced it has filed its Annual Report on Form 10-K for the year ended December 31, 2012, as well its Quarterly Reports on Form 10-Q for each of the quarters ended September 30, 2012 and March 31, 2013. As a result of these filings, Nile is now current with its obligations to file reports with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934, as amended.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, cenderitide, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure. More information on Nile can be found at http://www.nilethera.com.


'/>"/>
SOURCE Nile Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
2. Orexigen Therapeutics Announces Upcoming Clinical Data Presentations at American Diabetes Association Annual Scientific Meeting
3. Echo Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Over-Allotment Option by the Underwriter
4. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
5. Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China
6. Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics
7. Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America
8. Lineage Therapeutics Markets Authorized Generic Epinephrine Auto-Injector
9. Prime Therapeutics receives highest rating in 2013 customer satisfaction survey
10. Sorrento Therapeutics Receives Frost & Sullivans Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
11. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2019)... ... , ... The findings of a new study on lung injury associated with ... by toxic chemicals rather than the inhalation of oily substances. , The study, ... Report of Eight Cases ,” by Sanjay Mukhopadhyay, MD, FASCP, et al., was published ...
(Date:10/15/2019)... ... ... Twiggy Bean, Ph.D., wanted to educate others about the divorce bullying epidemic so ... become truly child focused. This objective prompted her to write “Divorce Bullying: An Epidemic ... be a divorce bully!” (published by Balboa Press), a guidebook that serves as a ...
(Date:10/11/2019)... ROCK, Ark. (PRWEB) , ... October 11, 2019 ... ... Case Management Week starting October 13, 2019, to recognize the dedication, compassion and ... management is a collaborative process, providing a unique and vital link between patients, ...
Breaking Medicine Technology:
(Date:10/8/2019)... ... October 08, 2019 , ... Dr. Amir HagShenas of Silicon Valley ... CA experience relief from this common and treatable condition. Dr. HagShenas’ goal is to ... from living with uncomfortable symptoms, including tender and bleeding gums, and to prevent gum ...
(Date:10/8/2019)... ... October 08, 2019 , ... As a world-renowned expert ... associate professor with the University of Maryland Department of Veterinary Medicine, continues to ... Communications, Shi and his lab have discovered a new pathway by which liver ...
(Date:10/8/2019)... ... October 08, 2019 , ... At the ... 4medica® President Gregg Church will inform conference attendees how the 4medica ... management-by starting with the right, clean patient data. The single platform interfaces to ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... ... selected CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) ... Digital Health Awards was to select companies that promote faster, better, more cost-effective ...
(Date:10/8/2019)... MARIETTA, Ga. (PRWEB) , ... October 08, 2019 , ... On November 9, 2019, husband ... host a No Cost Dental Day . 2019 marks the ninth consecutive year that ... of the community who are in need. , This event has always had a great ...
Breaking Medicine News(10 mins):